Merck & Co., Inc. (MRK) operating KPIs
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)
Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%
Latest, FY2025
8,856
Period ended Dec 31, 2025
Change on a year earlier
+17.3%
7,548 in FY2024
History
13 years
Since FY2013
Sources
9
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Geographic Long-Lived Assets — EMEA ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 8,856 | +17.3% | Form 10-K (filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | 7,548 | -0.2% | Form 10-K (filed 2025-02-25) ↗ |
| FY2023 | Dec 31, 2023 | 7,562 | +8.1% | Form 10-K (filed 2024-02-26) ↗ |
| FY2022 | Dec 31, 2022 | 6,993 | +15.0% | Form 10-K (filed 2023-02-24) ↗ |
| FY2021 | Dec 31, 2021 | 6,081 | +14.4% | Form 10-K (filed 2022-02-25) ↗ |
| FY2020 | Dec 31, 2020 | 5,314 | +28.7% | Form 10-K (filed 2022-02-25) ↗ |
| FY2019 | Dec 31, 2019 | 4,129 | +11.4% | Form 10-K (filed 2022-02-25) ↗ |
| FY2018 | Dec 31, 2018 | 3,706 | +17.6% | Form 10-K (filed 2019-02-27) ↗ |
| FY2017 | Dec 31, 2017 | 3,151 | +15.3% | Form 10-K (filed 2018-02-27) ↗ |
| FY2016 | Dec 31, 2016 | 2,732 | -3.9% | SEC Filing ↗ |
| FY2015 | Dec 31, 2015 | 2,844 | -8.8% | Form 10-K (filed 2016-02-26) ↗ |
| FY2014 | Dec 31, 2014 | 3,120 | -6.8% | Form 10-K (filed 2016-02-26) ↗ |
| FY2013 | Dec 31, 2013 | 3,346 | – | Form 10-K (filed 2016-02-26) ↗ |
Cite this data
StockData. (2026). Merck Geographic Long-Lived Assets — EMEA ($M) ($M), annual FY2013–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/db_geo_emea_ppe
See every metric in the Merck KPI table. Data updated Oct 26, 2026.